Introduction
Mitchel P. Goldman and Robert A. Weiss Phlebology and Treatment of Leg Veins
Chapter Contents
Venous Anatomy, Physiology, and Pathophysiology�����������������������������2650
Physical Examination of the Phlebology Patient��������������������������������������2651
Laboratory Evaluation of the Superficial Venous System���������������������2652
Compression in Sclerotherapy and Venous Disease������������������������������2653
Sclerosing Solutions������������������������������������������������������������������������������������������2654
Techniques for Treating Telangiectasias and Reticular Veins���������������2656
Larger Varicose Veins�����������������������������������������������������������������������������������������2657
Postsclerotherapy Compression��������������������������������������������������������������������2660
Complications�����������������������������������������������������������������������������������������������������2660
Ambulatory Phlebectomy��������������������������������������������������������������������������������2662
Targeting the Saphenofemoral Junction ��������������������������������������������������2663
Key features
Superficial telangiectasias, reticular veins, and varicose veins of the lower extremities are interconnected and develop after impairment of venous return
Poor venous return results from venous valvular incompetence or primary muscle pump failure
A pretreatment physical examination to assess the extent and cause of the venous abnormalities should be performed with the patient in a standing position
The physical examination should be supplemented by duplex ultra- sonography when saphenous vein reflux is suspected
Both preoperative and postoperative compression are important in the management of venous insufficiency
Sclerosing agents should destroy the entire vascular wall, producing permanent fibrosis of the vessel
The minimal concentration and volume of sclerosing agent needed to achieve the desired results should be used
All affected portions of the superficial venous system should be treated, ideally in one session and starting with the most proximal
Large veins should be treated before smaller veins, and veins should be treated from proximal to distal
FDA-approved sclerosing agents include sodium tetradecyl sulfate and polidocanol, both liquid and microfoam formulations
Hypertonic saline (11.7%–23.4%) and glycerin (72% mixed 2:1 with
1% lidocaine, with or without epinephrine) are not FDA-approved for vein sclerosis, making their usage off-label
The most common local side effects following injection of sclerosing agents are hyperpigmentation and telangiectatic matting and much less often cutaneous ulcers
Patients generally require one to three sclerosant injection treatment sessions, spaced at 6- to 8-week intervals
Utilizing tumescent anesthesia, incompetent saphenous veins and large tributaries over 4 mm in diameter can be effectively treated by ambulatory phlebectomy, radiofrequency or laser thermal ablation, or cyanoacrylate adhesive closure